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Physical activity (PA) is an important non-therapeutic tool in primary prevention and treat-
ment of diabetes mellitus (DM). To improve activity-based health management, patients 
need to quantify activity-related energy expenditure and the other components of total 
daily energy expenditure. This review explores differences between the components of 
total energy expenditure in patients with DM and healthy people and presents various 
tools for assessing the energy expenditure in subjects with DM. From this review, it 
appears that patients with uncontrolled DM have a higher basal energy expenditure 
(BEE) than healthy people which must be considered in the establishment of new BEE 
estimate equations. Moreover, studies showed a lower activity energy expenditure in 
patients with DM than in healthy ones. This difference may be partially explained by 
patient with DMs poor compliance with exercise recommendations and their greater 
participation in lower intensity activities. These specificities of PA need to be taken into 
account in the development of adapted tools to assess activity energy expenditure and 
daily energy expenditure in people with DM. Few estimation tools are tested in subjects 
with DM and this results in a lack of accuracy especially for their particular patterns of 
activity. Thus, future studies should examine sensors coupling different technologies or 
method that is specifically designed to accurately assess energy expenditure in patients 
with diabetes in daily life.
Keywords: type 2 diabetes, metabolic cost, physical activity, guideline, sensor
iNTRODUCTiON
In recent decades, a decrease in leisure activity followed by a rise in sedentary behaviors and the 
degradation of eating habits have been observed. These changes have led to an increasing risk of 
developing metabolic diseases such as diabetes mellitus (DM) (1–3). In 2004, Wild et al. (4) esti-
mated that 4.4% of the population worldwide will have diabetes in 2030 (representing 366 million 
people). Only 7 years later, Whiting et  al. (5) assessed that 366 million people had diabetes and 
projected an increase to 552 million people by 2030. Various solutions exist to combat this increasing 
prevalence (6). Physical activity (PA) has been shown to be the main factor in primary prevention. 
Accordingly, studies show a decrease of 15–67% in the relative risk of developing DM (7–11). When 
associated with a healthy diet, PA is also considered to be an imperative component in the treatment 
Abbreviations: AEE, activity energy expenditure; BEE, basal energy expenditure; DM, diabetes mellitus; IC, indirect calo-
rimetry; PA, physical activity; VCO2 , rate of carbon dioxide production; 
VO2, rate of oxygen consumption; TEE, total energy 
expenditure; TEF, thermic effect of food.
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of subjects with DM (12). Indeed, in the short term, appropriate 
exercise can decrease glycemia by burning the overflow of blood 
glucose to generate energy. Long term, PA can improve insulin 
sensitivity, glycemic control, systolic blood pressure, and weight 
loss. It can also increase VO2peak, reduce glycated hemoglobin and 
fasting plasma glucose, and finally, decrease the need for oral 
medications or insulin (13–18). All these improvements are 
considered sufficient to decrease the rate of diabetes complica-
tions (19) and the relative risk of all-cause mortality (20, 21). 
Nevertheless, due to the impaired glucose regulation, exercise 
duration and intensity must be considered attentively. Actually, 
long duration exercise without sugar intake may increase the 
risk of hypoglycemia. On the contrary, brief intense exercise may 
induce hyperglycemia requiring insulin intake. Underestimated 
energy expenditure may also lead to an underestimation of nec-
essary medication. In these cases, exercise as a therapeutic tool 
must be precisely programed into daily life in order to see benefits 
in patients with DM.
The aim of this article is twofold. First, it presents the dif-
ferences between the energy expenditure between of people 
with DM and healthy people. Second, it reports on the various 
methods for evaluating EE and their validity in subjects with DM.
eNeRGY eXPeNDiTURe iN SUBJeCTS 
wiTH DM
In the literature, a simple model defines the daily total energy 
expenditure (TEE) as the sum of the basal energy expenditure 
(BEE), the thermic effect of food (TEF), and the activity energy 
expenditure (AEE). BEE is the major component of internal 
heat produced. BEE, which is defined as the energy expended 
to maintain minimal metabolic activities during a non-active 
period, is the main component of TEE (60–70% of TEE) (22). 
The TEF symbolizes the energy used by the body when it pro-
cesses certain unrefined foods as lean meats, vegetables, and 
whole grains. AEE represents the energy expended through PA 
and volitional exercise and sports. AEE is the main parameter 
that allows modulation of TEE since it depends on the type of 
PA, its duration, and its intensity. Thus, in the sections below, we 
will present the differences between the three EE components in 
patients with DM and healthy people.
Bee in Subjects with DM
Studies exploring BEE in patients with DM report no difference 
in absolute BEE (22–25). Nevertheless, this preliminary result 
could be explained by the sample heterogeneity of these studies. 
Indeed, after adjusting for age, sex, and fat free mass (FFM), it 
appeared that people with uncontrolled DM (HbA1c ≥ 8%) had 
a BEE 7.7% higher than healthy people (25–30).
Several possible physiological mechanisms may induce changes 
in BEE. FFM explains 65–90% of the interindividual variation of 
BEE in healthy adults (31). In subjects with DM, fasting blood 
glucose (FBG) may be another independent determinant of BEE 
(26–29). Indeed, studies found a 3–8% increase in BEE in patients 
with DM with high FBG (>10  mmol/l), which returns to the 
normal after insulin therapy (26, 29). These results are supported 
by the study of Ryan et al. (22) who reported no increase in the 
absolute and adjusted BEE in patients with a treated and stable 
DM. These results have been explained by two hypotheses. First, 
BEE may be increased by a rise in the loss of glucose in the urine 
(glycosuria) (29). It has been shown that hyperglycemia can 
increase glycosuria by 30–80  g/day, which corresponds to an 
energy loss of about 120–320 kcal/day (32). Finally, the second 
hypothesis indicated that people with impaired glucose regula-
tion had an increase in fasting hepatic gluconeogenesis with the 
rise of glycemia (33). Gluconeogenesis is an important energy-
consuming process that transforms free fatty acid into glucose 
causing by the decrease of insulin plasma level.
Overall, these studies suggest that the increase in glycosuria 
and/or gluconeogenesis caused by hyperglycemia seems to be 
behind the high BEE observed in patients with DM with poor 
glycemic control.
Thermic effect of Food
Studies examining the effects of DM on the TEF estimated a lower 
TEF in patients with insulin resistance than in healthy people 
(23, 34). Another study assessing insulin-induced thermogenesis 
(defined as the percentage of increase in metabolic rate during 
an insulin/glucose infusion) showed a decrease from subjects 
without DM (11.7%) to patients with impaired glucose toler-
ance (7.3%) and finally patients with DM (6.5%) (35). Thus, it 
appears that TEF decreases progressively with the development 
of DM. Indeed, TEF is negatively correlated with FBG and insulin 
concentrations (both are predictors of insulin resistance). The 
decrease in TEF may be induced by a reduced rate of glycogenesis 
in the skeletal muscle (36) and an impaired activation of the sym-
pathetic nervous system (37). As discussed later in this report, 
TEF will not be studied further because it does not represent an 
adjustable component of TEE.
Activity energy expenditure in Subjects 
with DM
A few studies directly compare the AEE in free-living conditions 
of patient with DM and a control group and indicate a lower AEE 
in patients with DM than in healthy people (694 vs 1,086 kcal/day, 
respectively) (24, 38). Taken together, the results of these studies 
suggest that people with DM present a total AEE less than that 
of healthy people. This result may be explained by either a lower 
amount of PA in subjects with DM and/or for a similar activity, 
by a difference in mechanical or metabolic efficiency.
Physical activity guidelines give the minimal amount of exer-
cise required to maintain or to improve people’s health. These 
directives concern the general population as well as patients 
with DM. A first guideline recommends accumulating an AEE 
of at least 800 kcal/week or 600 MET.min/week to be sufficiently 
active (39). This recommendation conducted led to instructions 
for practicing PA at moderate intensity for a minimum of 30 min, 
5 days/week or vigorous PA for a minimum of 20 min, 3 days/
week, or accumulating 10,000 steps, daily or at least 5 days/week 
(40–42).
According to these guidelines, 31–54.6% of individuals 
with DM were considered inactive (no activity practiced) 
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and 13–53.6% insufficiently active. In the general population, 
5–62% over 45 years of age were defined as inactive and 9–43% 
insufficiently active. In addition, studies indicated a lower rate 
of patients with DM following the guidelines than in the gen-
eral population (12.4–43% vs 55.5–87.2% in healthy people) 
(43–53). When the number of steps was observed, patients 
with DM without neuropathy walked 3,292–9,049 steps/day 
on average (54–59). Mitsui et al. (60) showed that 12–27.1% of 
healthy people aged over 45 years of age walk more than 10,000 
steps/day while in Strycker et al. (56), no patients with DM fol-
lowed this recommendation and only 15% walked 7,500–9,999 
steps/day.
To further analyze the practice of PA, activities can be qualified 
by their type (leisure, recreational, domestic), by their intensity 
(light, moderate, vigorous), or by their duration. By question-
ing the activity preferences of 505 Mexican–American patients 
with DM, study reported that the most common activities were 
gardening (33.7%) and walking (31.8%) and the least frequent 
were jogging (2.4%), aerobic (2.3%), and swimming (1.3%) (44). 
Moreover, studies also reported that 33, 16, and 12% of patients 
with DM had at least one, two, and three or more regular activi-
ties in the month, respectively, and 71% achieved at least one 
10-min period/day of moderate PA and 26% at least one 10-min 
period/day of vigorous PA (44, 61). By using a questionnaire, 
Kriska et al. (62) estimated a lower number of PA hours/week 
in men with DM than in healthy men (12.1 vs 22.9 h/week) and 
found no difference in women. By contrast, Ford and Herman 
(63) showed that patients with DM were equally likely to have 
engaged in PA. Based on indirect calorimetry (IC), studies noted 
a higher 24-h spontaneous PA (+10.5%) and total activity counts 
in healthy people and pre-patients with DM than in individuals 
with DM (25, 64). By contrast, Fontvieille et al. (23) concluded 
that there was no difference in spontaneous PA between the two 
groups.
The lower AEE observed in patients with DM may result 
from a smaller amount of PA accumulated throughout the day. 
However, other parameters such as metabolic and mechanical 
efficiency can also reduce energy expenditure. With equal level of 
activity, different AEE may reflect the different use of energy fuel. 
Indeed, the energetic equivalent of 1 l of oxygen changes accord-
ing to the type of foodstuffs metabolized (in a simple model, 1 l 
of oxygen equals 5.05 and 4.48 kcal when carbohydrate and fat 
are oxidized, respectively). The respiratory quotient is an indica-
tor of the fuel substrate used and it is equal to the VCO2 divided 
by the VO2 (respiratory quotient = 1 for carbohydrate oxidation 
only and 0.70 for fat oxidation only). During moderate-intensity 
exercise (40–50% of VO2 max), studies found no significant dif-
ference between the respiratory quotient and VO2 of patients 
with DM and healthy people (65, 66). In a second hypothesis, 
mechanical efficiency may be another parameter explaining the 
difference in AEE between patient with DM and healthy people. 
For instance, walking is one of the most convenient daily PA 
recommended for increasing TEE. Studies of patients with DM 
showed a decrease in comfortable walking speed, cadence, and 
stride length and an increase of plantar pressure at the heel, 
mid-foot, and first metatarsophalangeal joint as compared with 
the control group (67, 68). Moreover, it was also demonstrated 
that patients with DM have a less total concentric work in lower 
limb than healthy people (69), but more cocontraction in the 
muscles at the ankle and knee joint during the stance period 
(70). This altered gait pattern observed in patients with DM 
seems to reflect a stabilization strategy to compensate for the 
development of peripheral neuropathy (diminished sensory 
information and maximum strength of the lower limbs). At 
speeds of walking range from 0.6 to 1.6 m/s, Petrovic et al. (66) 
presented a general pattern of a higher cost of walking (express 
as milliliters per kilogram per minute) in diabetic patients with 
neuropathy (significant difference at all speed of walking) and 
in diabetic patients without neuropathy (significant difference at 
1.4 and 1.6 m/s) in comparison with healthy subjects. However, 
Maiolo et al. (71) found no significant difference in net EE of 
walking (at three different intensities) between patients with DM 
and healthy people.
In light of the previous results, the lower AEE in subjects with 
DM seems to be due to a low level of daily PA with more low 
intensity activities and an energetic inefficiency during walk-
ing. Due to the complex nature of PA, AEE assessment requires 
precise and adapted tools. In the remainder of our review, we will 
describe potential tools (validated for use in daily life) that are 
suitable for research with patients with DM.
ASSeSSMeNT OF eNeRGY eXPeNDiTURe 
iN SUBJeCTS wiTH DM
Methods for evaluating Bee in Subjects 
with DM
Measure of BEE is typically taken by IC. Although these 
methods are very accurate, they require significant human 
and financial resources. Thus, equations have been proposed 
to simply estimate the BEE with variables such as age, height, 
or weight. Many of these equations were constructed with data 
from the general population and then tested in people with DM 
(Table 1).
The Harris–Benedict equation is most frequently used 
to estimate BEE in the general population, but studies in 
patients with DM have presented mixed results. Many studies 
show a significant overestimation of BEE with this equation 
(RMSE1 = 160–184 kcal/day) (29, 78–80). Huang et al. (30) also 
found an overestimation of 3.3% in men with DM, but an under-
estimation of −3.1% in women. Finally, Miyake et al. (81) and de 
Figueiredo Ferreira et al. (82) observed no significant difference 
with IC (MD2 = −19 to 42.3 kcal/day). With the Mifflin–St Jeor 
equation, studies in patients with DM show an under/overestima-
tion of BEE by −126 to 160 kcal/day (80, 81, 83), or no significant 
difference (29, 78). The Ganpule equation presented no difference 
with the reference measure (bias3 = 4.5%) (79) or underestimated 
BEE by −110 kcal/day (81). Those developed by Schofield and 
Rodrigues showed no significant difference with the reference to 
1 RMSE, root mean square error.
2 MD, mean deviation.
3 Bias, mean percentage error between estimated and measured BEE.
TABle 2 | equations to estimate basal energy expenditure (kcal/day) derived from patient with diabetes or mixed population.
Reference equation Population base
Gougeon et al. (29) 375 + (85 × Wt) − (48 × FM) + (63 × FBG) n = 65. Obese, with diabetes mellitus
Huang et al. (30) 71.767 − (2.337 × A) + (257.293 × Sex) + (9.996 × Wt) + (4.132 × ht) + (145.959 × DSI) n = 1088. Obese, with and without DM
Martin et al. (80) Female: 803.8 + (0.3505 × A) × (BMI − 34.524) − (135 × Race) + (15.866 × FFM) + (50.90 × DSI) n = 166. Lean and obese, white and black, 
with and without DMMale: 909.4 + (0.3505 × A) × (BMI − 34.524) − (135 × Race) + (15.866 × FFM) − (9.10 × DSI)
Ikeda et al. (79) (10 × Wt) − (3 × A) + (125 × Sex) + 750 n = 68. Japanese, patients with type 1 and 
type 2 diabetes, lean and overweight
Wt, weight (kg); ht, height (cm); A, age (years); Sex, 1 for male and 0 for female; BMI, body mass index (kg/m2); FFM, fat free Mass (kg); Race, 1 for black and 0 for white; DSI: 1 for 
patient with diabetes and 0 for healthy; FBG: fasting blood glucose (mM).
TABle 1 | Most popular equations to estimate basal energy expenditure (kcal/day) derived from the general population.
Reference equation Population base
Harris and Benedict (72) Female: 655.1 + (9.6 × Wt) + (1.86 × ht) − (4.68 × A) n = 239. Young, white, and lean
Male: 66.5 + (13.75 × Wt) + (5.9 × ht) − (6.76 × A)
Ganpule et al. (73) [(48.1 × Wt) + (23.4 × ht) − (13.8 × A) + (547.3 × Sex) − 423.5]/4.186 n = 137. Healthy lean Japanese
Schofield (74) Female: [(0.034 × Wt + 3.653) × 1,000]/4.186 n = unclear. Older obese subjects
Male: [(0.048 × Wt + 3.538) × 1,000]/4.186
Mifflin et al. (75) Female: (10 × Wt) + (6.25 × ht) − (5 × A) − 161 n = 498. Lean and obese
Male: (10 × Wt) + (6.25 × ht) − (5 × A) + 5
Owen (76) 186 + (23.6 × FFM) n = 104. Lean and obese, different ethnic
Bernstein et al. (77) Female: 844 + (7.48 × Wt) − (0.42 × ht) − (3 × A) n = 202. Obese
Male: −1032 + (11 × Wt) + (10.2 × ht) − (5.8 × A)
Wt, weight (kg); ht, height (cm); A, age (years); Sex, 1 for male, 0 for female; BMI, body mass index (kg/m2); FFM, fat free mass (kg); FM, fat mass (kg).
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subjects with DM [MD = 55 kcal/day (p = 0.065) and −17.6 kcal/
day (p = 0.845), respectively]. The other equations tested in dia-
betic population overestimated the BEE (RMSE = 155–209 kcal/
day, bias = 5.9–12.3%) except for those of Owen and Bernstein, 
which underestimated BEE (MD = −62 to −53.5 kcal/day for the 
Owen equation and bias = −11.6 to −13.9% for the Bernstein 
equation) (79–81).
To improve the BEE estimate, other equations taking into 
account the physiological specificities of subjects with DM were 
developed (Table 2) and compared with equations established for 
the general population, and with IC (Table 3). The Huang and 
Martin equations presented comparable coefficients of determi-
nation (r2 = 0.75 and 0.79, respectively) and had better results as 
compared with the Harris–Benedict equation (30, 80). Besides, 
de Figueiredo Ferreira et  al. (83) showed an overestimation of 
BEE (MD = 115 kcal/day) in women with DM with this equation. 
The Ikeda and Martin equations presented a lower RMSE (103 
and 136 kcal/day, respectively) than the other general equations 
(140–209 kcal/day) (79, 80). Finally, the Gougeon equation, tak-
ing into account the glycemic status, presented no significant dif-
ference with IC [MD = 7.4 kcal/day (p = 0.845) and bias = −0.5 
and 1.6%] (29, 83).
If BEE in subjects with DM cannot be accurately assessed 
using direct or IC, it can be adequately estimated using equa-
tions. The results of the aforementioned studies suggest that BEE 
in subjects with DM is better determined by using specific and 
adapted equations. Thus, the best results were obtained with the 
Gougeon equation and this may be due to the inclusion of the 
FBG as a variable.
evaluation of Free-living Activity energy 
expenditure in Subjects with DM
Among the tools for assessing AEE, the doubly labeled water 
method and direct/IC are considered to be the gold standards. 
Although these different tools accurately estimated TEE and 
AEE, these methods cannot be used by a patient with DM to 
estimate his/her AEE and daily EE daily. For everyday use, many 
field evaluation tools for estimating AEE have been developed 
and tested in subjects with DM, such as diaries, questionnaires, or 
motion sensors. These methods and tools are often classified into 
two categories: subjective and objective methods.
Subjective Methods
Subjective methods include processes that usually require 
subjects to record their professional, home, and leisure activi-
ties. Among them, activity recall, logs, or questionnaires are 
declarative methods that provide a detailed account (nature, 
intensity, duration) of all daily PA. The AEE and TEE are then 
determined using the factorial method (84), where each activ-
ity intensity was weighted by its intensity expressed in Met, as 
it is referred to the compendium (85), then multiplied by its 
duration. As a reminder, one MET is equivalent to the BEE (1 
MET = 3.5 ml/kg/min of oxygen consumption or 1 kcal/kg/h). 
At least, when added to the measured or predicted BEE, it is 
possible to predict the AEE and TEE with the sum of all activ-
ity estimates during the day. Thus, the use of questionnaires 
is widely reported in the literature on the topic because they 
are easy to use for large epidemiologic surveys. Nevertheless, 
TABle 3 | References and results of studies comparing predictive basal energy expenditure with the gold standard in patients with type 2 diabetes.
Reference Population equation Results
Miyake et al. (81) n = 30; healthy Japanese (n = 10), with  
IGT (n = 7)  
and with DM (n = 13)
Harris–Benedict In DM—MD = −19 kcal/day
Ganpule In DM—MD = −110 kcal/day‡
Schofield In DM—MD = +55 kcal/day
Owen In DM—MD = −62 kcal/day
Mifflin–St Jeor In DM—MD = −126 kcal/day‡
Huang et al. (30) n = 1,088; DM = 142; obese subjects with and  
without DM
Huang R2 = 0.75
Harris–Benedict DM—bias = −3.1 to 3.3%†
Merghani et al. (78) n = 80; obese subjects with DM (n = 40) Mifflin–St Jeor In DM—no significant difference (p = 0.164)
Harris–Benedict In DM—overestimate by 11%‡
de Figueiredo Ferreira et al. (83) n = 28; sedentary Brazilian women Harris–Benedict MD = 42.3 kcal/day; bias = 5.9%
Mifflin–St Jeor MD = −69.6 kcal/day; bias = −2.6%
Huang MD = 115 kcal/day; bias = 11.3%†
Owen MD = −53.5 kcal/day; bias = −0.5%
Gougeon MD = 7.4 kcal/day; bias = 2.8%
Ikeda et al. (79) n = 60; lean and overweight Japanese, patients  
with type 1 (n = 6), type 2 diabetes (n = 54)
Ikeda RMSE = 103.0 kcal/day; bias = 4.8% (ns)
Harris–Benedict RMSE = 184.0 kcal/day; bias = 9.8% (ns)
Ganpule RMSE = 140.0 kcal/day; bias = 4.5% (ns)
Gougeon et al. (29)  n = 39; obese with DM (n = 32) and healthy  
obese subjects (n = 7)
Harris–Benedict Bias = 11.6% in men† and 4.8% in women†
Owen Bias = 2.3% in men and −5.3% in women†
Mifflin–St Jeor Bias = 1.8% in men and −0.7% in women
Bernstein Bias = −11.6% in men† and −13.9% in women†
Gougeon Bias = −0.5% in men and 1.6% in women
Martin et al. (80) n = 166; lean and obese subjects without DM  
(n = 97), with IGT (n = 22), with DM (n = 47)
Martin RMSE = 136.0 kcal/day (ns)
Harris–Benedict RMSE = 160.1 kcal/day (ns)
Mifflin–St Jeor RMSE = 160.3 kcal/day (ns)
Owen RMSE = 163.2 kcal/day (ns)
IGT, impaired glucose tolerance; DM, diabetes mellitus; bias, mean percentage error between estimated and measured BEE (%); RMSE, root mean squared error (kcal/day); MD, 
mean of difference between estimated and measured BEE (kcal/day); †p < 0.05; ‡p < 0.001; ns, not specified.
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few studies examined their validity with reference measures in 
subjects with DM.
The Modifiable Activity Questionnaire is a short survey 
created for the assessment of PA level (average hour/week of 
occupational and leisure activities over the past year) or energy 
expenditure in a variety of populations and age groups (86). 
Studies show that this questionnaire is both reliable and valid 
through direct comparisons with doubly labeled water (r = 0.75) 
(87) and accelerometer (r = 0.62) (86) in adults with DM. The 
International Physical Activity Questionnaire is most frequently 
used in epidemiologic research. It asks subjects about their PA 
during past week. Studies comparing the AEE estimated by this 
questionnaire with those estimated with accelerometer found 
a positive correlation in patients with DM with a correlation 
coefficient ranging from 0.24 (n =  143, p <  0.05) (88) to 0.53 
(n =  31, p =  0.002) (89). The two questionnaires refer to the 
frequency and duration of activities and calculate an estimated 
AEE in kcal/week.
Subjective methods suffer from acknowledged limitations due 
to the subject’s ability to modify the information collected (90). 
Moreover, the use of the factorial method to assess the AEE may 
be inaccurate when applied to individuals with different fat mass 
or FMM. Indeed, the compendium was developed to identify 
different classes of PA and normalize MET intensities in healthy 
populations (85). Studies confirmed that the normally used 1 
MET value overestimated the resting VO2  (35%) and BEE (20%) 
in healthy adults and overestimated BEE in overweight and obese 
subjects (91, 92).
Objective Methods
Objective methods include tools that are based on physiological 
data (skin temperature or heart rate), mechanical data (pedometer, 
accelerometer, or inertial sensor), or a combination of both such 
as the SenseWear Armband (BodyMedia, Pittsburgh, PA, USA) 
or the Actiheart (Mini-Mitter Co., USA). The accurate measure-
ment of TEE and AEE in subjects with DM is very challenging 
because, as demonstrated previously, patients with DM perform 
primarily low intensity PA, which may influence the assessment 
of AEE in several tools (93, 94). Therefore, these devices must be 
validated specifically for this population.
Few devices have been evaluated in people with DM. Mignault 
et al. (95) used the SenseWear Armband in six patients with DM 
for a 10-day free-living period to estimate their AEE and then 
compared it with the doubly labeled water based estimation. No 
significant difference was found between the two methods with 
a mean error of 78 kcal/day (r = 0.97). Machac et al. (94) evalu-
ated the SenseWear Armband and the Omron HJ-720 (Omron 
Healthcare, Kyoto, Japan) under three walking conditions (3 km/h, 
0%; 4 km/h, 0%; 5 km/h, 5%) in comparison with IC in 19 patients 
with DM. Their results showed a large overestimation with both 
devices at the lower speeds (MD = 70 and 81% at 3 km/h and 75 
and 78% at 4 km/h for the Omron and Armband, respectively). 
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On the contrary, both tools underestimated the AEE at 5 km/h, 
5% (−7.3% for the Omron and −7.8% for the Armband).
As studies involving patients with DM are rare, the results 
of measurements for individuals with physical activities 
similar to those of patients with DM (low walking speed, light 
intensity exercise) could be enlightening. Studies in overweight 
and obese people without DM compared the Ormon and the 
SenseWear Armband with IC showing a similar overestimation 
of AEE during an exercise test (96, 97). In older adults, Mackey 
et  al. (98) showed that the SenseWear Armband presented 
no difference from the gold standard for the assessment of 
TEE, but underestimated AEE by 18.5–26.8%. Colbert et  al. 
(99) found RMSE of 185, 210, and 213 kcal/day for Actigraph 
(ActiGraph, LLC, USA), the SenseWear Armband, and NL-2000 
(New-Lifestyles, Inc., Lee’s Summit, MO, USA), respectively. 
In another study, the Caltrac (Hemokinetics, Inc., Madison, 
WI, USA) underestimated TEE by −55 to −50% and no cor-
relation was found with the double labeled water (100, 101). 
In their study of elderly men, Rafamantanantsoa et  al. (102) 
compared TEE estimated by a heart rate monitor (Accurex 
Plus, Polar Electro Oy, Kempele, Finland) and an accelerometer 
(LifeCorder, Suzuken Co., Japan) with the doubly labeled water 
estimate. The heart rate method gives a better estimation of 
TEE (MD = 57 vs −542 kcal/day for accelerometry) but pre-
sented a higher intra-individual variation than the LifeCorder 
(coefficient of variation =  15 vs 7% for the accelerometer). 
As observed, objective methods suffer from acknowledged 
limitations. Accelerometry-based tools demonstrated poor 
accuracy at slow walking speeds and a decrease in precision 
with increasing body mass index (93). The device based on 
heart rate had a high variation in accuracy because the relation 
between heart rate and energy expenditure is not linear during 
rest and light intensity activity (103, 104). Yet, this range of 
intensities represented a major part of daily life activities in 
type 2 diabetic person.
Consequently, limited methods tested in people with DM may 
be used to self-check the calories burned daily. Currently, new 
technologies are accessible and marketed for estimating TEE or 
AEE and need to be tested in diabetic population.
Future Method for evaluating Aee in 
Subjects with DM
As previously discussed, different methods exist for the assess-
ment of TEE or AEE, but few have been validated in people with 
DM. Future research should address the weaknesses of methods 
already tested or experiment with new devices, perhaps by com-
bining several technologies.
Accelerometry showed higher error particularly during low 
intensity activities and cycling (99, 105, 106). In order to over-
come this limitation, Bonomi et al. (107) demonstrated that the 
AEE estimate via accelerometry can be improved if it is combined 
with detection of the type of activity. These results are interest-
ing because the use of data provided by only one accelerometer 
through a decision tree allows the correct detection of activity 
in 93% of cases (105). Kwapisz et al. (108) found similar result 
(91.7%) with a smartphone in detecting six activities of daily 
life. Several studies reported great accuracy in estimating AEE 
compared with IC (RMSE =  0.69–1.25 METs and MSE =  0.25 
METs) and a lower error as compared to another method 
(MSE = 2.05 METs for the Actiheart) (109–111). Inertial sensors 
consisting of a three dimensions accelerometer and gyroscope 
and a magnetometer can be used to identify the type of activity 
performed like previous accelerometers (112). These methods 
based on activity recognition could be a reliable solution for esti-
mating more precisely the AEE in subjects with DM. Finally, the 
Actiheart (combining an accelerometer and a heart rate moni-
tor) demonstrated high accuracy in standardized and free-living 
conditions for the prediction of AEE in healthy adults, but need 
to be tested in people with DM (113, 114).
SUMMARY AND CONClUSiON
This review emphasizes that there are differences between 
energy expenditure in patients with DM and healthy people. 
Patients with DM presented a higher BEE than healthy people. 
This difference seems to be due to an increase in FBG resulting 
in a higher glycosuria or gluconeogenesis. In addition, people 
with DM seem to have a lower AEE than healthy people. This 
review highlights that this lower AEE in patients with DM 
could be linked to a lower amount of activity (low compliance 
with PA recommendations) and the prevalence of low inten-
sity activities. However, more studies should be conducted 
to determine the influence of diabetic altered gait on energy 
expenditure during PA. All these results demonstrate the need 
to develop adapted tools and methods to estimate free-living 
total energy expenditure in patients with DM. The results of 
this review indicate that there are valid equations for estimating 
BEE in patients with DM, but few of the methods tested give 
an accurate assessment of TEE and AEE in daily life. Other 
methods, such as those based on activity recognition with wear-
able sensors should be considered in the future to improve the 
estimation of daily TEE in subjects with DM. However, these 
possibilities need to be tested under everyday life conditions 
with patients with DM.
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